GeneBio Systems
CDKN2A Polyclonal Antibody
CDKN2A Polyclonal Antibody
SKU:E-AB-19334
Couldn't load pickup availability
Size: 200μL
Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.
Exp date: 12 months
Category ID_II: Primary Antibodies
Category ID_III: Polyclonal Antibodies
Abbreviation: CDKN2A
Target Synonym: CCM2;CDK4 inhibitor p16 INK4;CDK4I;CDKN2;CDKN2A;Cell cycle negative regulator beta;CMM2;Cyclin dependent kinase 4 inhibitor A;Cyclin dependent kinase inhibitor 2A (melanoma p16 inhibits CDK4);Cyclin Dependent Kinase Inhibitor 2A;Cyclin dependent kinase inhibitor 2A isoform 4;Cyclin dependent kinase inhibitor 2A isoforms 1/2/3;Cyclin dependent kinase inhibitor p16;INK4;INK4A;MLM;MTS1;Multiple tumor suppressor 1;p14;p16;P16INK4;p16INK4a;p19;p19Arf;TP16
Research Areas: Cancer;Cell Biology;Epigenetics and Nuclear Signaling
Conjugation: Unconjugated
Host: Rabbit
Species reactivity: Human
Application: IHC
Isotype: IgG
Clonality: Polyclonal
Clone NO.:
UNIProt ID: P42771
Accession:
Background: This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53.
Concentration: 0.4 mg/mL
Immunogen: Synthetic peptide of human CDKN2A
Buffer: PBS with 0.05% NaN3 and 40% Glycerol,pH7.4
Purification method: Antigen affinity purification
Dilution: IHC 1:50-1:200
Calculated MW:
ObservedMW:
